|Bid||0.7200 x 0|
|Ask||0.7300 x 0|
|Day's Range||0.7200 - 0.8000|
|52 Week Range||0.6150 - 2.9300|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 12, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.75|
Cannabis stocks rose Tuesday and were on track to end a six-day losing streak, buoyed by news that a congressional committee is advancing a bill that would lift the federal ban on cannabis and overturn past convictions.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly-owned subsidiary FoliEdge Academy, has entered into an Educational Products Distribution Agreement with one of the largest Canadian post-secondary institutions to introduce cannabis education courses and programs. FoliEdge Academy is an interactive cannabis education and certification platform, featuring proprietary, interactive courses customized for large organizations. FoliEdge Academy course content forms an important element of Aleafia Health’s scalable cannabis health and wellness ecosystem, integrating with the Company’s medical cannabis clinic network with 70,000 patients seen to date.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly owned subsidiary, Emblem Cannabis Corp., has secured two Health Canada licence amendments that expand processing capacity, allowing for the sale of new product formats at its Paris Processing facility. The amendments apply to the licensed and operational Paris location, which processes all of the Company’s extraction, packaging and order fulfilment for Canadian and international sales.
Aleafia Health Inc . (TSX: ALEF) (OTC: ALEAF ) reported Tuesday with third-quarter total revenue of $5.29 million, up 34% from $3.95 million in the previous quarter. The company posted an adjusted EBITDA ...
Ultra low-cost production at $0.08 cost per gram at outdoor facilityAverage net revenue per gram equivalent of $15.11 for medical cannabis salesMedical cannabis sales up 43%.
Cannabinoid content per gram only slightly lower than identical strains grown indoorsCritical quality control tests successfulApproximately 1,000 kg yield per acre in Zone.
TORONTO, Oct. 23, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2019 Third Quarter Financial Results on November 12,.
(APHA) will be the first marijuana company to report quarterly earnings since last week’s cannabis stock selloff. Its fiscal first-quarter earnings announcement is scheduled for Tuesday, after the market closes. Aphria stock (ticker: APHA) is down about 17% so far this year through Friday’s close at $4.71, while the S&P 500 index has risen 19%.
Aphria (NYSE:APHA) shareholders continued to be disappointed as the APHA stock price drops. Despite this disappointment, no one is talking abut one piece of potentially bearish news -- and that should concern investors.Source: Shutterstock Aleafia Health (OTCMKTS:ALEAF) is a vertically integrated cannabis health and wellness company with a large presence in Canada. It produces cannabis-infused oils and capsules and it operates 25 medical clinics and education centers in Canada.So what is this bearish news? In September of last year, Aphria and Emblem Cannabis, a wholly owned subsidiary of Aleafia, came to an agreement that Aphria was to supply up to 175,000 kilograms of cannabis to Emblem. Had all gone according to plan, the five-year agreement should have started in May 2019.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOn Tuesday Aleafia said that it was terminating this agreement. This clearly was not an amicable breakup. It its statement, Aleafia attributed its decision to "Aphria's failure to meet its supply obligations under the supply agreement." A Contentious RelationshipWhen a company makes a statement like this without trying to put any spin on it, it is usually a sign of a contentious relationship. For example, Aleafia could have used more diplomatic language and said something along the lines of "after careful consideration both companies have mutually decided that it was in their best interest to end the agreement."Aleafia's statement clearly puts a negative light on APHA. Aleafia also assured shareholders that this termination of the agreement would not have any material effect on its operations.What should concern Aphria's shareholders, in my opinion, is its response to the announcement. It did not offer any explanation or try to fight back in any way. In response the company said "We are disappointed that Aleafia has chosen to terminate its Agreement with Aphria Inc. The Company had every intention of fulfilling its obligations under the Agreement."So … what happened? Why couldn't Aphria keep up its side of the agreement? Was it due to logistics or operational issues? Was it due to the fact that Aphria isn't growing enough to meet the demand? A Closer Look at Aphria StockThe ambiguity and lack of explanation in this statement would concern me if I was a shareholder. Aphria's most recent investor presentation stated that the company's annual production capacity of its combined facilities is 255,000 kilograms. If the agreement with Aleafia was for up to 175,000 kilograms over five years, that could be up to 35,000 kilograms a year -- which is more than 10% of the total capacity.Will Aphria have similar problems supplying other companies? It next reports earnings on Oct. 15. This will probably be a topic of discussion on the earnings call. If there isn't more clarity on why Aleafia terminated the agreement, it could be a very bearish signal for APHA.APHA stock is currently testing -- and possible breaking support -- around the $5 level. There was support at this level in August and early October.At the time of this writing Mark Putrino did not have any holdings in the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Super Boring Stocks to Buy With Super Safe Returns * 10 Winning Stocks to Buy and Stick With for the Long Haul * Don't Give Up on These 4 Cannabis Stocks The post Aleafia's Announcement Should Concern Aphria Stock Investors appeared first on InvestorPlace.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announces that it has provided Aphria Inc. (TSX: APHA, NYSE: APHA) (“Aphria”) with a formal notice of the termination, effective October 7, 2019, of the wholesale cannabis supply agreement (the “Supply Agreement”) dated September 11, 2018 between Aphria and Emblem Corp. (“Emblem”), a wholly-owned subsidiary of the Company, providing for the provision by Aphria of up to 175,000 kg equivalents of cannabis products over an initial five-year term, commencing May 1, 2019.
Features initial 115,000 kg of dried flower equivalent annual extraction capacity, with ability for further expansion on-site2,775% increase over Company’s current annual.
TORONTO, Oct. 02, 2019 -- The Board of Directors of Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has appointed Lea Ray as its new.
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to provide guidance anticipating the Company will achieve positive net income for the three month period ended September 30, 2019. “Through prudent capital allocation, coupled with strong cannabis revenue growth, we now expect to deliver the first profitable quarter in Aleafia Health’s history, a major milestone. This will mark our second consecutive quarter featuring both substantial expense reductions and increased revenues as we continue to drive towards sustainable, compliant growth that will deliver real benefits to our stakeholders,” said Aleafia Health CEO Geoffrey Benic.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”)’s wholly owned subsidiary, Aleafia Farms Inc., has acquired the farmland directly adjacent to its Port Perry Outdoor Grow facility. The purchase will allow the Company to commence its Outdoor Grow Phase II expansion, adding an additional 60 acres of cannabis cultivation area, for a total of 86 acres.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to provide a corporate update and report its Second Quarter 2019 financial results for the period ended June 30, 2019. Aleafia Health has filed its consolidated financial statements and related management’s discussion and analysis, both of which are available on Aleafia Health’s profile at www.SEDAR.com. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “The foundation that our team has built over the last year is now beginning to prove its worth as we report marked improvements with record revenue generated, significant cost reductions and a growing base of active, registered medical cannabis patients,” said Aleafia Health CEO Geoffrey Benic.
TORONTO, Aug. 07, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) will announce its 2019 Second Quarter Financial Results on.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is announcing that its wholly owned subsidiary, Emblem Cannabis Corporation, has completed the largest adult-use cannabis order (the “Order”) in the Company’s history. The value of the Order is expected to generate proceeds from the sale of cannabis exceeding $1.0 million, and has been shipped to a Canadian provincial government for distribution to online and retail consumers. The single Order features all of the Company’s product formats and 17 individual product SKUs.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to announce that on July 12, 2019, Aleafia Health’s wholly-owned subsidiary, Aleafia Farms Inc., secured a License Amendment (the “Licence”) under Health Canada’s Cannabis Regulations authorizing cannabis cultivation for the entirety of the Company’s Port Perry Outdoor Grow facility. The Licence immediately increases the Company’s licensed and operational outdoor cultivation area from 292,000 sq. ft. to over 1.1 million sq. ft. As previously announced on June 10, 2019, Aleafia Farms received approval for cultivation in Zone 1 of the Outdoor Grow facility, and days later completed the planting of Canada’s first legal, large-scale outdoor crop.
TORONTO, July 11, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has been added to The Cannabis ETF (NYSE: THCX) (“THCX”),.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has received multiple Export Permits (the “Permits”) from Health Canada, which allow the Company to begin its first international cannabis product shipment. The Company expects to ship its branded medical cannabis oils in the next month, which will be distributed by Australian Licensed Producer CannaPacific Pty. Limited (“CannaPacific”).
TORONTO, June 27, 2019 (GLOBE NEWSWIRE) -- (ALEF.TO) (ALEAF) (ARAH.F) Aleafia Health Inc. (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced public offering of convertible debenture units (the “Convertible Debenture Units”) of the Company at a price of $1,000 per Convertible Debenture Unit for aggregate gross proceeds of $40,250,000 (the “Offering”), which includes the full exercise of the over-allotment option. The Offering was led by Mackie Research Capital Corporation and BMO Capital Markets, and included Canaccord Genuity Corp. (together, the “Agents”).
Aleafia Health Inc. (the “Company”) (ALEF.TO) (OTC: ALEAF) (ARAH.F) is pleased to announce the results of the vote on the election of directors at its annual and special meeting of shareholders held on June 17, 2019 (the “Meeting”). On a vote conducted by ballot, all seven nominees set out in the management information circular of the Company dated May 10, 2019 were elected as directors of the Company to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. The voting results based on the ballots cast are set out below. Final voting results on all matters voted on at the Meeting have been filed with the Canadian securities regulators on the Company’s SEDAR profile at www.sedar.com.